Paper
16 April 1998 Optical fluorescence and Raman biopsy of squamous cell carcinoma from the head and neck
Yuanlong Yang, C. H. Liu, Howard E. Savage, Stimson P. Schantz M.D., Robert R. Alfano
Author Affiliations +
Proceedings Volume 3250, Optical Biopsy II; (1998) https://doi.org/10.1117/12.305364
Event: BiOS '98 International Biomedical Optics Symposium, 1998, San Jose, CA, United States
Abstract
Fluorescence, excitation, diffuse reflectance and FT-IR Raman spectral scans of squamous cell carcinoma of the head and neck have been studied. Eleven specimens of squamous cell carcinoma in larynx, lymph node, throat, grand, soft palate and epiglotts and nine corresponding normal specimens was tested. The excitation spectral differences between squamous cell carcinoma and normal were investigated in the protein spectral range 260 nm to 300 nm. The ratios intensity at various excitation wavelengths were used as criterion to separate carcinoma and normal tissues. The t- test of these parameter have been made. The P values of all these three parameters are less than 0.005. The statistical results of sensitivity and specificity of using three parameters compared to pathological results are about 90 percent. The Raman spectroscopy was measured. Characteristics vibrational modes were used to separate out carcinoma and correlated with excitation spectroscopy data.
© (1998) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Yuanlong Yang, C. H. Liu, Howard E. Savage, Stimson P. Schantz M.D., and Robert R. Alfano "Optical fluorescence and Raman biopsy of squamous cell carcinoma from the head and neck", Proc. SPIE 3250, Optical Biopsy II, (16 April 1998); https://doi.org/10.1117/12.305364
Lens.org Logo
CITATIONS
Cited by 5 scholarly publications.
Advertisement
Advertisement
RIGHTS & PERMISSIONS
Get copyright permission  Get copyright permission on Copyright Marketplace
KEYWORDS
Tissues

Raman spectroscopy

Neck

Head

Luminescence

Lymphatic system

Tumors

Back to Top